$RGC is the highest performing inventory of all 2021 IPOs
2021 was the busiest yr for offers since 2000, with a record-breaking IPO rush of 1,035 listings within the US, with the biotech and healthcare sectors main the way in which, accounting for 36% of all IPO exercise.
Whereas most traders are busy reviewing shares of their present portfolio, it might come as a shock which firm got here in first for inventory return. Though it’s presently not a family identify, any savvy investor ought to undoubtedly preserve this inventory on their radar: Regencell Bioscience (NASDAQ:RGC). RGC is the highest performing inventory of all 2021 IPOs in line with stockanalysis.com/ipos/2021/. As of August 1, 2022, RGC continues to be ranked #1 with a 237% return above its IPO value of $9.50.
A June 2022 article talked about that RGC’s whole cumulative brief quantity is over 19 million shares. Whereas the inventory has suffered from brief sellers’ assaults since its itemizing, RGC has carried out nicely. RGC has roughly 2.6 million tradable atypical shares out there and has maintained a low float because the founder and CEO has repeatedly bought RGC atypical shares from the open market.
RGC’s Stable Basis
As talked about above, RGC is carefully held by the CEO who owns over 81% of the corporate. He has used $5.9 million of his private funds to buy RGC shares from the open market since its IPO.
His constant share purchases convey his confidence, dedication and conviction within the firm and is placing his cash the place his mouth is. There are few firms that have the CEO proudly owning this a lot of the enterprise. The corporate’s complete administration group has additionally prolonged the lock-up interval of their share choices, which reveals they’re collectively dedicated to their purpose and mission, which is to avoid wasting and enhance lives.
Comparability to 2022 IPO Prime Performer
A current inventory that has gone to the moon since its mid-July 2022 IPO is an organization based by Mr. Li Ka-Shing’s Cheung Kong Group and Hutchison Whampoa in 2003, AMTD Digital (NYSE:HKD). HKD’s IPO value was $7.80 and has gained over 9,000% since, closing at $742.00 on August 1, 2022. Though RGC is the #1 performer of 2021 IPOs, this pales compared with the present efficiency of HKD. Astute merchants who’ve a watch for forensic evaluation in firms with low float and outsized brief curiosity are certainly very blissful.
RGC was additionally listed in mid-July and relies in Hong Kong. In truth, there are a couple of similarities between the 2 firms. Each RGC and HKD are based by people (Mr. Au for RGC and Mr. Li for HKD), who imagine in philanthropy and giving again to society. HKD’s upward trajectory which has delivered an unimaginable 90 occasions bagger in a brief period of time has additionally attracted many brief positions in opposition to the corporate. Beneath is a desk outlining the important thing metrics:
learn extra>>> https://www.benzinga.com/common/biotech/22/08/28316977/a-look-into-the-top-performing-ipo-stock-of-2021
